Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation

Abstract TP53 is one of the most ubiquitously altered genes in human cancer. The biological impact of rare variants, particularly those located within noncoding regions, remains poorly understood. From interrogation of clinical massively parallel sequencing data from over 55,000 tumors, which includ...

Celý popis

Podrobná bibliografie

Hlavní autoři:	M Herman Chui, Ciyu Yang, Nikita Mehta, Vikas Rai, Ahmet Zehir, Amir Momeni Boroujeni, Marc Ladanyi, Diana Mandelker
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2022-01-01
Edice:	The Journal of Pathology: Clinical Research
Témata:	p53 TP53 intronic mutation pathogenic variant cancer
On-line přístup:	https://doi.org/10.1002/cjp2.242
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!